VIVUS, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States and focuses on developing innovative therapies for obesity and sexual health. Founded in 1991, the company has achieved significant milestones, including the launch of its flagship product, Qsymia, which addresses obesity management through a unique combination of active ingredients. With a commitment to advancing patient care, VIVUS also offers the erectile dysfunction treatment, Stendra, which stands out for its rapid onset of action. The company has established a strong market position, recognised for its dedication to research and development in niche therapeutic areas. VIVUS continues to strive for excellence, aiming to improve the quality of life for patients through its specialised products and services.
We don't have data for VIVUS, Inc., but we can show you information about their parent organization instead.
View parent company